Advocacy intelligence hub — real-time data for patient organizations
Ensem Therapeutics — PHASE1, PHASE2
Eli Lilly and Company — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Makoto Tahara, MD, PhD
National Cancer Center Hospital East
Lillian Siu, MD
Princess Margaret Hospital, Canada
Central Contact
Astellas Pharma Global Development
Kris Ann P Schultz, MD
Children's Minnesota
AeRang Kim, MD, M.D
Children's Oncology Group
📍 BETHESDA, MD
Smita Jha, M.D., M.D
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
📍 BETHESDA, MD